Mark Sheptoff Financial Planning’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,450
| Closed | -$251K | – | 360 |
|
|
2019
Q3 | $251K | Sell |
3,450
-300
| -8% | -$21.8K | 0.17% | 84 |
|
|
2019
Q2 | $308K | Hold |
3,750
| – | – | 0.21% | 75 |
|
|
2019
Q1 | $265K | Hold |
3,750
| – | – | 0.19% | 79 |
|
|
2018
Q4 | $169K | Sell |
3,750
-300
| -7% | -$13.5K | 0.14% | 86 |
|
|
2018
Q3 | $229K | Hold |
4,050
| – | – | 0.16% | 94 |
|
|
2018
Q2 | $271K | Hold |
4,050
| – | – | 0.2% | 88 |
|
|
2018
Q1 | $236K | Hold |
4,050
| – | – | 0.16% | 92 |
|
|
2017
Q4 | $261K | Sell |
4,050
-1,200
| -23% | -$77.3K | 0.17% | 94 |
|
|
2017
Q3 | $276K | Sell |
5,250
-300
| -5% | -$15.8K | 0.19% | 97 |
|
|
2017
Q2 | $260K | Buy |
5,550
+500
| +10% | +$23.4K | 0.18% | 95 |
|
|
2017
Q1 | $250K | Buy |
5,050
+1,200
| +31% | +$59.4K | 0.18% | 90 |
|
|
2016
Q4 | $233K | Sell |
3,850
-100
| -3% | -$6.05K | 0.17% | 90 |
|
|
2016
Q3 | $262K | Hold |
3,950
| – | – | 0.19% | 83 |
|
|
2016
Q2 | $220K | Hold |
3,950
| – | – | 0.16% | 86 |
|
|
2016
Q1 | $133K | Sell |
3,950
-300
| -7% | -$10.1K | 0.11% | 107 |
|
|
2015
Q4 | $192K | Buy |
4,250
+1,150
| +37% | +$52K | 0.16% | 92 |
|
|
2015
Q3 | $122K | Buy |
3,100
+400
| +15% | +$15.7K | 0.11% | 122 |
|
|
2015
Q2 | $168K | Buy |
2,700
+600
| +29% | +$37.3K | 0.14% | 111 |
|
|
2015
Q1 | $131K | Hold |
2,100
| – | – | 0.11% | 126 |
|
|
2014
Q4 | $118K | Buy |
+2,100
| New | +$118K | 0.1% | 125 |
|